NHLBI Trial Concludes No Benefit for Hydroxychloroquine in COVID-19

THURSDAY, Nov. 12, 2020 -- Hydroxychloroquine is not beneficial for adults hospitalized with COVID-19, according to the formal conclusion of a study funded by the U.S. National Heart, Lung, and Blood Institute (NHLBI) and published online Nov. 9 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news